Neko Health, a Swedish medical screening company co-founded by David Ek and Hjalmar Nilsonne, has launched in New York as demand for its one-hour body scans pushes its global waitlist above 300,000 people. The company has raised nearly $1 billion and charges $500 per scan, which is not covered by insurance but should qualify as an eligible Health Savings Account expense. Its technology examines blood, skin and metabolism, combining blood biomarkers with computer vision (AI that interprets visual data). Farooq Abbasi of Preface Ventures, an investor in Neko Health, said preventive care should be cheaper and more accessible in the United States, where he believes utilization is limited partly by cost concerns. Abbasi, who has undergone two scans, said the product expanded from 15 biomarkers in his first scan to 55 in his latest. Neko Health is eyeing broader U.S. expansion but still faces scaling and regulatory-approval challenges.